Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 11/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20371123 | 0.79 | KIF11 (0.51) | KIF11KCNH2LMNAHTTSMN1; SMN2 | |
| SCHEMBL715991 | 0.79 | AGTR1 (0.38) | KIF11LMNAHTTSMN1; SMN2CA4 | |
| SCHEMBL20371105 | 0.78 | KIF11 (0.53) | KIF11KCNH2LMNAHTTSMN1; SMN2 | |
| SCHEMBL17928455 | 0.78 | KIF11 (0.46) | KIF11KCNH2LMNAHTTSMN1; SMN2 | |
| SCHEMBL21562153 | 0.77 | CA4 (0.46) | KIF11KCNH2LTA4HCA4 | |
| SCHEMBL17173364 | 0.77 | CA4 (0.46) | KIF11KCNH2LTA4HCA4 | |
| SCHEMBL8454432 | 0.77 | KIF11 (0.45) | KIF11KCNH2LTA4HCA4 | |
| SCHEMBL10495868 | 0.76 | KIF11 (0.45) | KIF11KCNH2HTT | |
| SCHEMBL16214813 | 0.76 | KIF11 (0.50) | KIF11KCNH2 | |
| SCHEMBL3487683 | 0.76 | KIF11 (0.50) | KIF11KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436138-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2013-05-07 | — | — | US | disclosed |
| US-20120053124-A1 | BINDER FOR C-REACTIVE PROTEIN | MODPRO AB (SE) | 2012-03-01 | — | — | US | disclosed |
| US-8017347-B2 | Binder for C-reactive protein | MODPRO AB (SE) | 2011-09-13 | — | — | US | disclosed |
| US-20090305298-A1 | Binder for C-Reactive Protein | MODPRO AB (SE) | 2009-12-10 | — | — | US | disclosed |
| EP-2007801-A1 | BINDER FOR C-REACTIVE PROTEIN | Modpro AB (SE) | 2008-12-31 | — | — | EP | disclosed |
| WO-2007117215-A1 | BINDER FOR C-REACTIVE PROTEIN | MODPRO AB (SE) | 2007-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305298-A1 | Binder for C-Reactive Protein | C1QBP, RBP1, MYCBP | KIF11 4602/4885KCNH2 4495/4885LMNA 2495/4885 |
| US-20120053124-A1 | BINDER FOR C-REACTIVE PROTEIN | C1QBP, RBP1, MYCBP | KIF11 4602/4885KCNH2 4495/4885LMNA 2495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.